Aspergillosis

Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI)

Pharmacokinetics of Voriconazole in Adult ECMO Patients

PTX3-targeted Antifungal Prophylaxis

Isavuconazole in Critically Ill Patients: Efficacy and Safety

Pulmonary Aspergillosis in Tuberculosis Patients

Prospective Observational Study on the Incidence of Opportunistic Fungal Infections

Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study

Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi

Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis

Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Immune Regulation in Chronic Aspergillus Infection After COVID-19 Infection

Mucormycosis in COVID-19

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection

The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.

The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis

Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)

THYME AND CARVACROLL Nanoparticle Effect on Fungi

Aspergillus-specific PCR Assay in Cerebrospinal Fluid Samples for Detection of Central Nervous System Aspergillosis